论文部分内容阅读
目的：探讨20例食管癌动脉灌注化疗药物的应用价值。材料与方法：全部病例均经X线食管造影、内窥镜检查并确定组织形态学类型，共进行了38次穿刺插管注入化疗药物。结果：表明选择性动脉化疗对治疗中晚期食管癌的近期疗效较明显，且不同形态的食管癌的疗效存在差异，其中半年、一年的生存率分别为80％、35％、无严重的并发症出现。结论：经导管注入化疗药物是治疗中晚期食管癌一种安全、行之有效的方法，其远期疗效尚在观察，建议选择性血管内介入治疗配合食管内支架置入效果更佳。
Objective: To explore the application value of 20 arterial infusion chemotherapy drugs for esophageal cancer. Materials and Methods: All cases were subjected to X-ray esophageal angiography, endoscopy, and histomorphology. A total of 38 puncture cannulations were injected into chemotherapy drugs. Results: The selective curative effect of arterial chemoembolization for the treatment of advanced esophageal cancer was more obvious. There were differences in the efficacy of different forms of esophageal cancer. Among them, the half-year and one-year survival rates were 80%, 35%, and no serious concurrent. Symptoms appear. Conclusion: Transcatheter injection of chemotherapy drugs is a safe and effective method for the treatment of advanced esophageal cancer. Its long-term efficacy is still being observed. It is recommended that selective endovascular intervention combined with esophageal stenting be more effective.